Rare heterozygous loss-of-function variants in the human GLP-1 receptor do not associate with cardiometabolic phenotypes.
Josefine U MelchiorsenKimmie V SørensenJette Bork-JensenHüsün S KizilkayaLaerke Smidt GasbjergAlexander Sebastian HauserJørgen RungbyHenrik T SørensenAllan Arthur VaagJens S NielsenOluf PedersenAllan LinnebergBolette HartmannAnette Prior GjesingJens Juul HolstTorben HansenMette Marie RosenkildeNiels GrarupPublished in: The Journal of clinical endocrinology and metabolism (2023)
Since no homozygous LoS nor pLoF variants were identified and heterozygous carriers had similar cardiometabolic phenotype as non-carriers, we conclude that GLP-1R may be of particular importance in human physiology, due to a potential evolutionary intolerance of harmful homozygous GLP1R variants.